Efficacy and Safety Study of Stemchymal® in Polyglutamine Spinocerebellar Ataxia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of the clinical trial is to study the therapeutic efficacy and safety of Stemchymal® infusions for polyglutamine spinocerebellar ataxia treatment by a randomized, double-blind, placebo-controlled study design. Eligible subjects will receive Stemchymal® through intravenous infusion.
Epistemonikos ID: 9d49d607f92f44ef171233de0e5615773f7233fd
First added on: May 12, 2024